Piracetam‐induced immune thrombocytopenia

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2011 English Publisher:WileyJournal:Epileptic Disorders, volume 13, pages 226-226 (issn: 1294-9361, eissn: 1950-6945,

Copyright policy )

Authors: Dries Deeren; Lien Deleu;

doi: 10.1684/epd.2011.0438

Piracetam‐induced immune thrombocytopenia

- Summary
- Metrics

Abstract

epd.2011.0438 Auteur(s) : Dries Deeren DDeeren@hhr.be, Lien Deleu Department of Hematology, H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium To the editor We refer to the paper of Oghlakian et al. on levetiracetam-induced thrombocytopenia (2010). As has been demonstrated by others previously, levetiracetam was shown in this study to cause thrombocytopenia, most likely regulated by the immune system (Meschede et al., 2008; Peer Mohamed and Prabhakar, 2009). Piracetam has primarily been used [...]

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average